Breast Cancer
News
FDA approves neoadjuvant pembro for triple-negative breast cancer
It is the first immunotherapy regimen to be approved for high-risk early-stage triple negative breast cancer.
Latest News
The robot comes to mastectomy, but cancer outcomes data not attached
Clinical trials are underway in the United States to explore the use of robotic surgical devices for nipple-sparing mastectomy, but investigators...
From the Journals
Cancer mortality continues to drop in females as breast cancer reversal looms
Gains were strongest for melanoma and lung cancer, while ground was lost to uterine cancer.
Recap
Therapeutic Approaches in Advanced Breast Cancer
Dr Susan Domchek, from the University of Pennsylvania, discusses the importance of identifying molecular characteristics of metastatic breast...
From the Journals
Huge trial casts doubt on bisphosphonates for breast cancer
New results show no difference in disease-free survival, distant disease-free survival, and overall survival.
News
CDC notes sharp declines in breast and cervical cancer screening
The new data come from the National Breast and Cervical Cancer Early Detection Program, which provides cancer screening services to women with low...
From the Journals
No increase in breast cancer risk with fertility treatments
Latest News
Rapid update to ASCO breast cancer guidelines after OlympiA data
The American Society of Clinical Oncology (ASCO) now recommends offering 1 year of adjuvant...
Conference Coverage
DCIS: Biosignature helps guide postlumpectomy decisions
The tool shows promise for identifying those whose cancer is likely to recur despite undergoing postlumpectomy radiotherapy.
Feature
Freezing breast cancer to death avoids surgery: Why not further along?
Conference Coverage
Promising HER2+/HR– breast cancer survival with de-escalated therapy